Form 4 for FDMT 4D Molecular Therapeutics, Inc.
Accepted 2023-06-12 00:00:00 ET · period of report 2023-06-08 · accession 0001610717-23-000153 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-12 | 2023-06-08 | FDMT | Bizily Scott | Chief Legal, HR Off | S - Sale+OE | $20.85 | -3,750 | 1,737 | -68% | -$78.2K |
| D | 2023-06-12 | 2023-06-08 | FDMT | Bizily Scott | Chief Legal, HR Off | M - OptEx | $8.04 | +3,750 | 5,487 | +216% | +$30.1K |
| D | 2023-06-12 | 2023-06-08 | FDMT | Bizily Scott | Chief Legal, HR Off | M - OptEx | $0.00 | -3,750 | 48.8K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-08 | S | D | 3,750 | $20.85 | 1,737 | D | — | — | |
| 2 | Common | Common Stock | 2023-06-08 | M | A | 3,750 | $8.04 | 5,487 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-06-08 | M | D | 3,750 | $0.00 | 48,750 | D | $8.04 · — to 2032-08-31 | 3,750 Common Stock | (F2) The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company. |